drugset / Trial / NCT03638076
The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The Safety, Antiviral Activity, and pharmacokinetics of Morphothiadine Mesilate Capsules/Ritonavir Tablets in Patients with Chronic Hepatitis B
Timeline
- Start
- 2017-07-26
- Primary completion
- 2018-11-22
- Completion
- 2018-11-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLS4 | Other / unclassified | 120 mg | — |
| Subject | RTV | Unknown | 100 mg | — |